CriticalFeb 27,
2026
Major Metformin Recall Expanded Due to NDMA Contamination
Additional lots of extended-release metformin tablets recalled after higher-than-acceptable levels were detected.
Read MorePrescription Drug Recalls
Contamination, mislabeling, and potency issues affecting medications you and your family may be taking.
CriticalFeb 24,
2026
Ozempic Lawsuits Allege Severe Gastroparesis and Stomach Paralysis
Patients report debilitating stomach paralysis, severe vomiting, and intestinal blockages after using the drug.
Read MoreCriticalFeb 20,
2026
Dupixent Linked to Serious Eye and Joint Complications
Reports include severe conjunctivitis, joint pain, and inflammatory arthritis after treatment.
Read MoreCriticalFeb 17,
2026
Depo-Provera Lawsuits Allege Link to Brain Tumors
Long-term users report increased risk. Lawsuits allege manufacturer failed to warn patients.
Read MoreCriticalFeb 14,
2026
FDA Warns of Contaminated Eye Drops Linked to Infections
Several over-the-counter eye drop brands recalled due to bacterial contamination and reported vision loss.
Read MoreWarningFeb 10, 2026
Blood Pressure Medication Recalled for Incorrect Dosage Labeling
A packaging error placed higher-dose tablets in lower-dose bottles, risking dangerous drops in blood pressure.
Read MoreWarningFeb 6, 2026
Children’s Liquid Ibuprofen Recalled Over Concentration Concerns
Select batches may contain a higher concentration than labeled, posing overdose risk for young children.
Read MoreModerateFeb 2,
2026
Generic Thyroid Medication Recalled for Subpotency Issues
Affected lots may contain less active ingredient than specified, potentially worsening symptoms.
Read More